264 filings
Page 5 of 14
8-K
hqa 47rt366
10 Nov 20
Larimar Therapeutics Reports Third Quarter 2020 Operating and Financial Results
4:23pm
8-K
zzccq2sw
30 Oct 20
Entry into a Material Definitive Agreement
5:02pm
S-8
d38e6 crsuwn
2 Oct 20
Registration of securities for employees
5:19pm
8-K/A
w2h dobjeat5f1
29 Sep 20
Departure of Directors or Certain Officers
4:39pm
8-K
zxe t2wmxn
29 Sep 20
Departure of Directors or Certain Officers
7:06am
EFFECT
hiccoqo4h2cb
2 Sep 20
Notice of effectiveness
12:15am
CORRESP
9dwzoc91lc5 9v8n
31 Aug 20
Correspondence with SEC
12:00am
UPLOAD
r42 giw0cb
24 Aug 20
Letter from SEC
12:00am
DEFA14A
eilo8z
19 Aug 20
Additional proxy soliciting materials
6:13am
8-K/A
q6aybazh8f41vzvkox
14 Aug 20
Unaudited Pro Forma Combined Financial Statements
4:56pm
8-K
w2okez2n
11 Aug 20
Larimar Therapeutics Reports Second Quarter 2020 Operating and Financial Results
7:38am
8-K
9byxhz5ca3xy63hq
6 Aug 20
Departure of Directors or Certain Officers
9:00am
EFFECT
t575pq8hc1b iy
15 Jul 20
Notice of effectiveness
12:15am
CORRESP
vigl2myi5xb 9kfp
13 Jul 20
Correspondence with SEC
12:00am
UPLOAD
23cwj3a9aoj
10 Jul 20
Letter from SEC
12:00am
S-8
hc0i0nl7vo629vq
26 Jun 20
Registration of securities for employees
5:28pm